Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evoke Pharma Q2 EPS $(0.62) Misses $(0.30) Estimate, Sales $3.752M Miss $3.796M Estimate

Author: Benzinga Newsdesk | August 14, 2025 07:04am
Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.30) by 106.67 percent. This is a 33.33 percent increase over losses of $(0.93) per share from the same period last year. The company reported quarterly sales of $3.752 million which missed the analyst consensus estimate of $3.796 million by 1.16 percent. This is a 47.08 percent increase over sales of $2.551 million the same period last year.

Posted In: EVOK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist